Skip to content

Clinical Study on Shugan Tiaoshen Acupuncture Intervention for Patients with Generalized Anxiety Disorder Under Epidemic Situation

Clinical Study on Shugan Tiaoshen Acupuncture Intervention for Patients with Generalized Anxiety Disorder Under Epidemic Situation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006843
Enrollment
Unknown
Registered
2022-12-01
Start date
2022-12-02
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized anxiety disorder

Interventions

Sponsors

Shenzhen Bao'an Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ( 1 ) Patients who met the above diagnostic criteria of generalized anxiety disorder in Chinese and Western medicine and were diagnosed in the context of the new coronavirus epidemic ; ( 2 ) Hamilton Anxiety Scale ( HAMA ) 14 determination = 14 points and < 29 points ; ( 3 ) Age = 18 years, = 65 years ; ( 4 ) those who have not received medication, physical or psychological treatment in the past three weeks, or those in stable condition ; signed informed consent and volunteered to participate in this study.

Exclusion criteria

Exclusion criteria: ( 1 ) Patients who do not meet the inclusion criteria ; ( 2 ) patients with a history of brain trauma, epilepsy, or accompanied by liver and kidney dysfunction, metal implants or severe physical organic diseases such as cardiovascular, cerebrovascular, liver and kidney ; ( 3 ) Patients with other anxiety symptoms of schizophrenia, bipolar disorder or other mental disorders, physical illness ; ( 4 ) Patients with previous or current suicide plan or behavior, psychotic symptoms or anxiety caused by alcohol, drug abuse or withdrawal after addiction ; ( 5 ) Patients with poor compliance or fear of acupuncture ; ( 6 ) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Related scale assessment ( Hamilton anxiety scale, state anxiety-trait anxiety questionnaire, life event scale, post-traumatic stress disorder self-rating scale );Efficacy Evaluation of Traditional Chinese Medicine;

Secondary

MeasureTime frame
chinese medicine syndrome scores;

Countries

China

Contacts

Public Contactzhou xiayun
carman2021@163.com19874205056

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026